News

What if an antibiotic that has been used for more than half a century could cure Parkinson's disease? This is the hope raised by a study of two researchers from the Brain & Spine Institute, Rita Raisman-Vozari, Emeritus Director of Research at the...

Why does multiple sclerosis progress more rapidly in some patients than in others? Why do some patients with multiple sclerosis succeed in repairing demyelination damage over the course of the disease and others not? A joint study led by Institut du...

In a new study, Mariam Chammat, post-doctoral researcher (FRM) and Prof Lionel Naccache (AP-HP, UPMC), team leader at the Institut du Cerveau, found that the renowned psychological phenomenon known as cognitive dissonance is closely linked to...

Myelin, a protective sheath that covers various nerve fibers, is essential in the transmission of nerve signals and enables proper function of the nervous system. Myelin degeneration causes severe illnesses including multiple sclerosis. Lamia...

From the early stages of Parkinson’s disease onwards, cardiovascular and respiratory disorders are relatively frequent. The team led by Stéphane Lehéricy and Marie Vidailhet at the Institut du Cerveau – ICM highlighted, for the very first time, a...

Nicolas Renier, a new team leader at the Institut du Cerveau - ICM, joined the Institute on the 1st January 2017. His work focuses on changes of connections between neurons in adulthood, using a new technique: 3D brain imaging through light-sheet...

Bruce Appel, a professor at the University of Colorado, School of Medecine and Children’s Hospital Colorado, spoke at the Institut du Cerveau - ICM on the 9th January 2017. His work focuses on understanding PMN cells differentiation and could...

The publication of Benedetta Bodini and Bruno Stankoff, researchers at Paris Brain Institute, on the use of a new imaging technique in multiple sclerosis, was selected by Lancet Neurology among the top 5 of 2016 to improve the understanding and...

A stage 3 clinical trial has proven the efficacy of lacosamide alone to treat focal seizures, specifically as a first-line treatment for newly diagnosed epilepsy.

Researchers from the “Experimental therapeutics of neurodegeneration” team led by Etienne Hirsch at the Brain and Spine Institute – Institut du Cerveau - ICM, Institut du Cerveau et de la Moelle épinière – and collaborators, have just published a...

Scientists from the French Blood Bank (Etablissement français du sang), in collaboration with several researchers including Stéphane Haïk, team leader at the Institut du Cerveau - ICM, have just developed a biological test capable of detecting the...

Prof Emmanuel Flamand Roze initiated a program entitled “The Move”, that uses miming to teach neurological semiology to medical school students. This novel teaching method, supported by the Institut du Cerveau - ICM and the IHU for its international...